Extension of Time to File SOU

ARISTOTLE

StageZero Life Sciences Ltd.

Request for Extension of Time to File a Statement of Use

PTO- 1581
Approved for use through 03/31/2024. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88292678
LAW OFFICE ASSIGNED LAW OFFICE 103
MARK SECTION
MARK ARISTOTLE (see, http://uspto.report/TM/88292678/mark.png)
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT ARISTOTLE
OWNER SECTION (current)
NAME StageZero Life Sciences Ltd.
MAILING ADDRESS 30-70 East Beaver Creek Road
CITY Richmond Hill, Ontario
ZIP/POSTAL CODE L4B3B2
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Canada
EMAIL XXXX
OWNER SECTION (proposed)
NAME StageZero Life Sciences Ltd.
MAILING ADDRESS 30-70 East Beaver Creek Road
CITY Richmond Hill, Ontario
ZIP/POSTAL CODE L4B3B2
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Canada
EMAIL XXXX
CORRESPONDENCE INFORMATION (current)
NAME Steven A. Abreu
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE trademarks@sunsteinlaw.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
CORRESPONDENCE INFORMATION (proposed)
NAME Steven A. Abreu
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE trademarks@sunsteinlaw.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
DOCKET/REFERENCE NUMBER 03907/2002
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION Medical diagnostic reagents and assays for testing blood for cancer; Medical diagnostic reagents and assays for testing blood for gastroenterology disorders, neurology disorders, cardiology disorders and autoimmune disorders; medical diagnostic test kits for Cancer screening
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 3
ONGOING EFFORT product or service research or development
ALLOWANCE MAIL DATE 09/24/2019
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 1
SUBTOTAL AMOUNT [EXTENSION FEE] 125
TOTAL AMOUNT 125
SIGNATURE SECTION
SIGNATURE /James R Howard-Tripp/
SIGNATORY'S NAME James Howard-Tripp
SIGNATORY'S POSITION Chief Executive Officer
DATE SIGNED 03/08/2021
SIGNATORY'S PHONE NUMBER 905.617.2742
SIGNATURE METHOD Sent to third party for signature
FILING INFORMATION
SUBMIT DATE Mon Mar 08 12:39:13 ET 2021
TEAS STAMP USPTO/ESU-XX.XX.XX.XX-202
10308123913423854-8829267
8-7702ca15b493ce033586f9c
dffc211786e33866d3b676c0d
bfa5de9dd30bfc35846-DA-39
110285-202103081215135108
98



PTO- 1581
Approved for use through 03/31/2024. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: ARISTOTLE (see, http://uspto.report/TM/88292678/mark.png)
SERIAL NUMBER: 88292678

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: StageZero Life Sciences Ltd., having an address of
      30-70 East Beaver Creek Road
      Richmond Hill, Ontario, L4B3B2
      Canada
      Email: XXXX
Proposed: StageZero Life Sciences Ltd., having an address of
      30-70 East Beaver Creek Road
      Richmond Hill, Ontario, L4B3B2
      Canada
      Phone:
      Fax:
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 09/24/2019.

For International Class 005:
Current identification: Medical diagnostic reagents and assays for testing blood for cancer; Medical diagnostic reagents and assays for testing blood for gastroenterology disorders, neurology disorders, cardiology disorders and autoimmune disorders; medical diagnostic test kits for Cancer screening

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the third extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension request: product or service research or development

Correspondence Information (current):
      Steven A. Abreu
      PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@sunsteinlaw.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED

Correspondence Information (proposed):
      Steven A. Abreu
      PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@sunsteinlaw.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /James R Howard-Tripp/      Date Signed: 03/08/2021
Signatory's Name: James Howard-Tripp
Signatory's Position: Chief Executive Officer
Signatory's Phone: 905.617.2742
Signature method: Sent to third party for signature

PAYMENT: 88292678
PAYMENT DATE: 03/08/2021

Serial Number: 88292678
Internet Transmission Date: Mon Mar 08 12:39:13 ET 2021
TEAS Stamp: USPTO/ESU-XX.XX.XX.XX-202103081239134238
54-88292678-7702ca15b493ce033586f9cdffc2
11786e33866d3b676c0dbfa5de9dd30bfc35846-
DA-39110285-20210308121513510898




uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed